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Progressive External Ophthalmoplegia has an unusual Inheritance Pattern
Depending on the Gene Involved.
➢ Mahdi Farah, Southern Maine Community College; South Portland, ME 04106
ABSTRACT
Progressive external ophthalmoplegia (PEO) is characterized by
weakness of the eye muscles or mainly by a loss of the muscle
functions in the eye (Ophthalmoplegia) and eyelid movement
(ptosis). The signs and symptoms typically appear or tend to begin
in early adulthood and slowly worsens over time and lead
paralysis of one or more extraocular muscles. People with PEO
may also have a general weakness of the skeletal muscles used for
movement (myopathy). PEO is a disease of mitochondrial origin
and it is mainly caused by defects or mutations in any of several
mitochondrial proteins. Mitochondria are structures in cells that
use oxygen to convert the energy from food into a form that cells
can use. It has different inheritance patterns depending on the gene
of the affected individual. Mitochondria have their own
chromosome and DNA replication system, including a unique
DNA polymerase, called polymerase gamma (Pol G). The aim of
this literature review is to discuss the types of PEO resulting from
mutations in the mitochondrial genome, as well as, how this
results in a maternal inheritance pattern.
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❖ MITOCHONDRIAL MUTATIONS:
❑ Progressive external ophthalmoplegia is transmitted as an autosomal
dominant trait. With the onset of symptoms usually occurring between
18 and 40 years of age. The main clinical manifestation of PEO is a
progressive weakness of the external eye muscles resulting in
blepharoptosis (an abnormal or low-lying upper eyelid margin) and
ophthalmoparesis (paralysis or weakness of the eye muscles).
❑ PEO can result from mutations in one of several different genes in the
mitochondria. For instance, PEO can be associated with mutations in the
POLG gene encoding a subunit of the mitochondrial DNA polymerase,
which is the only known DNA polymerase in human mitochondria and
is essential for mitochondrial DNA replication and repair. It is well
established that defects in mtDNA replication lead to mitochondrial
dysfunction and disease. .
❑ Perhaps surprisingly, mutations in nuclear genes have an effect on
mitochondrial DNA replication, but there's not a maternal inheritance
pattern because in most cases, there are 4 autosomal dominant
mutations that cause PEO encode the amino acid substitutions G923D,
R943H, Y955C and A957S in the polymerase domain of POLG.
❖ DEFINITION: Autosomal dominance is a pattern of inheritance characteristic
of some genetic diseases. "Autosomal" means that the gene in question is
located on one of the numbered, or non-sex, chromosomes. "Dominant" means
that a single copy of the disease-associated mutation is enough to cause the
disease.

Figure 3:
Although progressive external ophthalmoplegia (PEO) is part of a spectrum of
disorders with overlapping signs and symptoms, the primary symptom is muscle
weakness which is caused by defects in mitochondria with depletion of
mitochondrial DNA (mtDNA). MtDNA replication is important as it explains
the formation of deletions and point mutations associated with human disease
and aging. It's replicated by an assembly of proteins and enzymes including
DNA polymerase γ (pol γ) and its accessory protein, single-stranded DNA
binding protein (mtSSB), mtDNA helicase (Twinkle), and a number of
accessory proteins and transcription factors.
Ultimately, an autosomal dominant (nuclear) is causing mitochondrial problems
with DNA replication and no heteroplasmy ensures that the children will receive
a mix of normal and mutant mitochondria. The child will only be affected if a
threshold of mutant (critical mutation rate) mitochondria is reached.

FIGURE 1: The mitochondria is an organelle that can be
considered the power generator of the cell, converting
oxygen and nutrients into a form that cells can use. Mutations
or defects in the nuclear DNA of this organelle are responsible
for the condition, including mutations in the POLG resulting
in the progressive external ophthalmoplegia (PEO).
FIGURE 2: This individual is affected by a progressive
external ophthalmoplegia disease and presents a weakness or
paralysis of the eye muscles that move the eyes. Usually, affected
individuals have to turn their heads to see in different
directions, especially as the ophthalmoplegia worsens.

FIGURE 3: The POLG contains an exonuclease region, spacer, thumb
region and a finder region surrounded by two palms. It also illustrates
that there are many mutations in the PEO, but mutations in and around
the finger domain are autosomal dominant mutations, the only
mitochondrial disease that cosegregates with autosomal dominant (ad)
mutations in POLG. Nearly all of the adPEO mutations in POLG are
located in the polymerase domain of pol γ (Fig.3).
One of the first adPEO mutations to be discovered was the Y955C
mutation, and this was the first to be biochemically characterized. The
Y955C is a mutation, causing a 10- to 100-fold increase in misinsertion
errors, most likely as a consequence of a 45-fold decrease in binding
affinity for the incoming nucleoside triphosphate.
This enhanced mutagenesis is mitigated by a functional intrinsic
exonuclease activity resulting in only a 2-fold mutator effect for base-pair
substitutions by the exonuclease proficient Y955C enzyme.
In a subsequent study of four adPEO mutant variants, the Y955C and
R943H substitutions were predicted to interact directly with the incoming
dNTP by analysis of a structural model of the polymerase active site
based upon the solved crystal structure of T7 DNA polymerase.
Recombinant proteins carrying these substitutions retain less than 1% of
the wild-type (WT) polymerase activity and display a severe decrease in
processivity. The significant stalling of DNA synthesis and extremely low
catalytic activities of both enzymes are the two most likely causes of the
severe clinical presentation in R943H and Y955C heterozygotes.
The G923D and A957S substitutions retained less than 30% Wild Type
polymerase activity. This is consistent with the reduced clinical severity
of PEO in individuals heterozygous for the G923D and A957S mutations.
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